Alios BioPharma, Inc. is a biotechnology company located in South San Francisco, California that is developing novel medicines that treat diseases in virology by activating pathways in the innate immune system.   Alios is pursuing the development of both protein and small molecule therapeutics, each addressing major commercial market opportunities.

Alios is currently not hiring. Check back with us!

Latest News

October 16, 2009

Alios BioPharma Issued Broad U.S. Patent for Glyco-engineered Interferons

Read More...

August 13, 2009

Alios BioPharma, Inc. has appointed Plexxikon Founder and Chief Executive Officer K. Peter Hirth, Ph

Read More...